AI Article Synopsis

  • Myasthenia gravis (MG) is an autoimmune disease linked to the thymus and can be treated with thymectomy, but patients often face a risk of myasthenic crisis afterward.* -
  • Researchers analyzed 393 MG patients undergoing thymectomy to develop a scoring system based on clinical characteristics, identifying three key factors that predict the risk of a postoperative myasthenic crisis.* -
  • The predictive score, which ranges from 0 to 6, shows promising accuracy in forecasting myasthenic crises in both derivation and validation groups, with areas under the curve of 0.84 and 0.80 respectively.*

Article Abstract

Objective: Myasthenia gravis (MG) is an autoimmune disease mostly caused by autoantibodies against acetylcholine receptor associated with thymus abnormalities. Thymectomy has been proven to be an efficacious treatment for patients with MG, but postoperative myasthenic crisis often occurs and is a major complication. We aimed to develop and validate a simple scoring system based on clinical characteristics in the preoperative status to predict the risk of postoperative myasthenic crisis.

Methods: We studied 393 patients with MG who underwent thymectomy at 6 tertiary centers in Japan (275 patients for derivation and 118 for validation). Clinical characteristics, such as gender, age at onset and operation, body mass index, disease duration, MG subtype, severity, symptoms, preoperative therapy, operative data, and laboratory data, were reviewed retrospectively. A multivariate logistic regression with LASSO penalties was used to determine the factors associated with postoperative myasthenic crisis, and a score was assigned. Finally, the predictive score was evaluated using bootstrapping technique in the derivation and validation groups.

Results: Multivariate logistic regression identified 3 clinical factors for predicting postoperative myasthenic crisis risk: (1) vital capacity < 80%, (2) disease duration < 3 months, and (3) bulbar symptoms immediately before thymectomy. The postoperative myasthenic crisis predictive score, ranging from 0 to 6 points, had areas under the curve of 0.84 (0.66-0.96) in the derivation group and 0.80 (0.62-0.95) in the validation group.

Interpretation: A simple scoring system based on 3 preoperative clinical characteristics can predict the possibility of postoperative myasthenic crisis. Ann Neurol 2017;82:841-849.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.25087DOI Listing

Publication Analysis

Top Keywords

postoperative myasthenic
20
myasthenic crisis
16
predictive score
8
clinical characteristics
8
multivariate logistic
8
logistic regression
8
postoperative
5
myasthenic
5
clinical
4
clinical predictive
4

Similar Publications

Multimodal management and complete resection of invasive Type B3 thymoma with vascular reconstruction: a case report.

J Cardiothorac Surg

January 2025

Department of Thoracic Surgery, Guy's and St Thomas' NHS Foundation Trust, London, England.

Introduction: Thymomas and thymic carcinomas are rare anterior mediastinal tumours, accounting for 0.2-1.5% of all cancers.

View Article and Find Full Text PDF

Myasthenia gravis (MG) is an autoimmune neuromuscular junction disorder that rarely coexists with infectious thoracoabdominal aortic aneurysms (TAAA) requiring open repair. A 57-year-old patient with MG underwent elective thoracoabdominal aortic replacement. He was diagnosed with MG (Osserman classification II A).

View Article and Find Full Text PDF
Article Synopsis
  • Mild-to-moderate blepharoptosis can negatively impact appearance, with some patients hesitant to pursue surgery; Botulinum neurotoxin A (BoNT-A) injections offer a non-surgical alternative.
  • A study included 49 patients (39 females, 10 males) with various causes of eyelid ptosis, using BoNT-A injections and measuring outcomes through MRD-1 changes and patient questionnaires at multiple intervals.
  • Results showed significant eyelid elevation post-treatment, with most patients experiencing improvement and a high willingness to repeat the procedure, although the effects diminished after 24 weeks.
View Article and Find Full Text PDF

Background: Long-term survival outcomes are crucial for accurately determining the effectiveness of treatment in an indolent disease like thymoma. We aimed to analyze the clinical findings in terms of survival and relapse patterns with a median follow up of 105 months (8.7 years) in patients with thymoma and myasthenia gravis who underwent minimally invasive surgery between 2002 and 2015.

View Article and Find Full Text PDF

Early stage thymoma and the surgical extent paradigm.

Updates Surg

November 2024

Thoracic Surgery Department, Faculty İbn-I Sina Hospital, Ankara University School of Medicine, 06100, Sıhhiye, Ankara, Turkey.

Article Synopsis
  • The study examines the outcomes of complete thymectomy (CT) versus limited thymectomy (LT) in early stage thymoma patients who do not have myasthenia gravis.
  • 86 patients were analyzed, revealing that the CT group had more complications and deaths compared to the LT group, alongside a higher but not statistically significant recurrence rate.
  • The findings suggest that limited thymectomy could be a viable treatment option, yet future randomized controlled trials are needed for more conclusive evidence.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!